Thioridazine
"Thioridazine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
Descriptor ID |
D013881
|
MeSH Number(s) |
D02.886.369.843 D03.494.741.843
|
Concept/Terms |
Apo-Thioridazine- Apo-Thioridazine
- Apo Thioridazine
- ApoThioridazine
- Apotex Brand of Thioridazine Hydrochloride
Meleril- Meleril
- Novartis Brand of Thioridazine
- Thioridazine Novartis Brand
- Melleril
- Melleryl
- Arzneimittelwerk Dresden Brand of Thioridazine
- Mellaril
Melleretten- Melleretten
- AWD.pharma Brand of Thioridazine Hydrochloride
Melzine- Melzine
- Clonmel Brand of Thioridazine Hydrochloride
Thiozine- Thiozine
- Pinewood Brand of Thioridazine Hydrochloride
Thioridazine-neurazpharm- Thioridazine-neurazpharm
- Thioridazine neurazpharm
- Thioridazineneurazpharm
- neurazpharm Brand of Thioridazine Hydrochloride
Aldazine- Aldazine
- Alphapharm Brand of Thioridazine Hydrochloride
Rideril- Rideril
- DDSA Brand of Thioridazine Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Thioridazine".
Below are MeSH descriptors whose meaning is more specific than "Thioridazine".
This graph shows the total number of publications written about "Thioridazine" by people in this website by year, and whether "Thioridazine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1984 | 1 | 0 | 1 | 1985 | 0 | 1 | 1 | 1986 | 1 | 0 | 1 | 1990 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Thioridazine" by people in Profiles.
-
Carvey PM, Nath ST, Kao LC, Zhang TJ, Lin DH, Singh R, Amdur RL, Klawans HL. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53.
-
Carvey PM, Kao LC, Zhang TJ, Amdur RL, Lin DH, Singh R, Klawans HL. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300.
-
Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14.
-
Klawans HL, Carvey P, Tanner CM, Goetz CG. The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41.
-
Goetz CG, Carvey PM, Tanner CM, Klawans HL. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9.
-
Klawans HL, Bergen D, Bruyn GW, Paulson GW. Neuroleptic-induced tardiave dyskinesias in nonpsychotic patients. Arch Neurol. 1974 Apr; 30(4):338-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|